SLB
39
-3
SO
66
-5
ZBH
42
-12
NDAQ
56
-7
HCP
56
-4
VRSK
61
-5
GE
65
-3
QCOM
43
-7
CINF
43
-2
AVY
65
-2
MNST
54
2
HAS
38
-13
SRCL
64
17
JCI
44
-3
REGN
62
-2
SWK
68
-5
JNJ
48
-5
NWS
35
-8
VNO
56
-3
RHI
42
-2
SLB
39
-3
SO
66
-5
ZBH
42
-12
NDAQ
56
-7
HCP
56
-4
VRSK
61
-5
GE
65
-3
QCOM
43
-7
CINF
43
-2
AVY
65
-2
MNST
54
2
HAS
38
-13
SRCL
64
17
JCI
44
-3
REGN
62
-2
SWK
68
-5
JNJ
48
-5
NWS
35
-8
VNO
56
-3
RHI
42
-2
Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Fed rate cuts could send the stock market down

Here's my #1 free indicator to use now.
Buy
60

SAVA
Cassava Sciences

Last Price:
26.92
Seasonality Move:
4.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Potential crash warning signs flashing again on my charts

Here's my #1 indicator to try out now.

Cassava Sciences Price Quote

$26.92
+0.01 (+0.04%)
(Updated: September 9, 2024 at 6:45 PM ET)

Cassava Sciences Key Stats

Buy
60
Cassava Sciences (SAVA) is a Buy
Day range:
$26.50 - $29.80
52-week range:
$8.79 - $42.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
28.55
P/B ratio:
6.83%
Volume:
1.5M
Avg. volume:
3.5M
1-year change:
30.82%
Market cap:
$1.3B
Revenue:
$0
EPS:
$-1.41

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went down by -11.74% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price rose by 30.82% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $207.3M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 3.94

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$86.2M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $125.2M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$92K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Anavex Life Sciences Corp (AVXL)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • Sarepta Therapeutics Inc (SRPT)

Cassava Sciences Dividend Yield

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -219.25%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 75.00
Upside from Last Price: 178.71%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    20.7M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2M SAVA shares are owned by insiders